A multi-centre, randomised, double-blind 14-week extension study examining the long-term safety and efficacy profile of the ezetimibe/simvastatin combination tablet*-Reference-Cited by-同舟云学术

A multi-centre, randomised, double-blind 14-week extension study examining the long-term safety and efficacy profile of the ezetimibe/simvastatin combination tablet*

Published:2007-07-26 Issue:9 Volume:61 Page:1469-1480
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:

Author:

Ose L.,Johnson-Levonas A.,Reyes R.,Lin J.,Shah A.,Tribble D.,Musliner T.,

Publisher

Hindawi Limited

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1742-1241.2007.01402.x/fullpdf

Reference40 articles.

1. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT);Stamler;JAMA,1986

2. Cholesterol reduction: weighing the benefits and risks;Gaziano;Ann Intern Med,1996

3. Drug treatment of lipid disorders;Knopp;N Engl J Med,1999

4. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

5. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators;Sacks;N Engl J Med,1996

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing remnant lipoprotein cholesterol measurement methods to evaluate efficacy of ezetimibe/statin vs statin therapy;Journal of Clinical Lipidology;2019-11

2. Drug Development for Metabolic Diseases: Past, Present and Future;Metabolic Syndrome;2011-04-08

3. Lipid-lowering effects of ezetimibe and simvastatin in combination;Expert Review of Cardiovascular Therapy;2011-02

4. The Efficacy and Safety of Ezetimibe and Low-Dose Simvastatin as a Primary Treatment for Dyslipidemia in Renal Transplant Recipients;The Korean Journal of Internal Medicine;2009

5. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: Results from two open-label extension studies in hypercholesterolemic patients;Clinical Therapeutics;2008-12